Autonomic Dysfunction: A Driving Force for Myocardial Fibrosis in Young Duchenne Muscular Dystrophy Patients?

被引:37
|
作者
Thomas, Tamara O. [1 ]
Jefferies, John L. [1 ]
Lorts, Angela [1 ]
Anderson, Jeffrey B. [1 ]
Gao, Zhiqian [1 ]
Benson, D. Woodrow [2 ]
Hor, Kan N. [3 ]
Cripe, Linda H. [3 ]
Urbina, Elaine M. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA
[2] Childrens Hosp Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[3] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA
关键词
Duchenne; Cardiomyopathy; Myocardial fibrosis; Heart rate variability; Tachycardia; HEART-RATE-VARIABILITY; FREQUENCY-DOMAIN MEASURES; CIRCUMFERENTIAL STRAIN; DILATED CARDIOMYOPATHY; CARDIAC DYSFUNCTION; PERIOD VARIABILITY; INFARCTION; FAILURE; TIME;
D O I
10.1007/s00246-014-1050-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac manifestations of Duchenne muscular dystrophy (DMD) include progressive cardiac dysfunction and an elevated resting heart rate (HR). We hypothesized this elevated HR reflects autonomic dysfunction that can be identified by heart rate variability (HRV) analyses which will be associated with myocardial fibrosis by cardiac magnetic resonance imaging (cMR). DMD patients (N = 74) and controls (N = 17) had time and frequency domain HRV analyses calculated via Holter monitoring. Cardiac magnetic resonance imaging was performed on DMD cases only. chi (2) test, T test, ANOVA, and logistic regression were used to perform comparisons between groups. A p value of < 0.05 was used for statistical significance. DMD cases had higher resting average HR than controls (99.4 +/- A 8.9, 85.4 + 6.2, p < 0.001). Among HRV variables, decreases were seen in the following: standard deviation of R to R intervals, the percent RR intervals differing by > 50 ms from previous RR interval, the root-meansquare of successive differences of RR intervals, the standard deviation of the mean R to R segment (SDANN), low frequency, and high frequency domain, all p values 0.001. Maximum HR and SDANN most significantly associated with positive LGE on cMR (p = 0.008, p = 0.016). DMD cases on beta blocker had an average HR lower than those not on beta blocker (p = 0.009), but with no difference in HRV analysis. DMD patients have reduced HRV and therefore autonomic dysfunction prior to the onset of heart failure which is associated with myocardial fibrosis.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 50 条
  • [31] Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging
    Sean M. Lang
    Svetlana Shugh
    Wojciech Mazur
    Joshua J. Sticka
    Mantosh S. Rattan
    John L. Jefferies
    Michael D. Taylor
    Pediatric Cardiology, 2015, 36 : 1495 - 1501
  • [32] Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging
    Lang, Sean M.
    Shugh, Svetlana
    Mazur, Wojciech
    Sticka, Joshua J.
    Rattan, Mantosh S.
    Jefferies, John L.
    Taylor, Michael D.
    PEDIATRIC CARDIOLOGY, 2015, 36 (07) : 1495 - 1501
  • [33] Electrocardiographic abnormalities in very young Duchenne muscular dystrophy patients precede the onset of cardiac dysfunction
    James, Jeanne
    Kinnett, Kathleen
    Wang, Yu
    Ittenbach, Richard F.
    Benson, D. Woodrow
    Cripe, Linda
    NEUROMUSCULAR DISORDERS, 2011, 21 (07) : 462 - 467
  • [34] A comparison of swallowing dysfunction in Becker muscular dystrophy and Duchenne muscular dystrophy
    Yamada, Yuka
    Kawakami, Michiyuki
    Wada, Ayako
    Otsuka, Tomoyoshi
    Muraoka, Kaori
    Liu, Meigen
    DISABILITY AND REHABILITATION, 2018, 40 (12) : 1421 - 1425
  • [35] Evaluation of Cardiac, Autonomic Functions in Ambulant Patients with Duchenne Muscular Dystrophy
    Amritharekha Nayak
    Apoorva S B
    Mainak Bardhan
    R. Rashmi
    G. Arunachal
    P.V. Prathyusha
    Atchayaram Nalini
    T.N. Sathyaprabha
    Kaviraja Udupa
    SN Comprehensive Clinical Medicine, 5 (1)
  • [36] Cardiac fibrosis and endothelial dysfunction in duchenne muscular dystrophy: the role of Tenascin C
    Szabo, P. L.
    Hamza, O.
    Inci, M.
    Ebner, J.
    Hilber, K.
    Dietmar, A.
    Trojanek, S.
    Costantino, S.
    Paneni, F.
    Podesser, B. K.
    Kiss, A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 3) : S50 - S50
  • [37] Myocardial Tissue Characterization of Pediatric Patients With Duchenne Muscular Dystrophy
    Sunthankar, Sudeep
    George-Durrett, Kristen
    Crum, Kim
    Markham, Larry W.
    Soslow, Jonathan H.
    CIRCULATION, 2021, 144
  • [38] ECG ABNORMALITIES COMPARED TO EXTENT OF MYOCARDIAL FIBROSIS IN BOYS WITH DUCHENNE MUSCULAR DYSTROPHY
    Hor, Kan N.
    Subramanian, Sharath
    Moran, Tyler
    Lao, Kathleen
    Gnyawali, Bipul
    Cripe, Linda
    Zareba, Karolina
    Raman, Subha
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1534 - 1534
  • [39] Identification of Serum miRNA Biomarkers That Detect Myocardial Fibrosis in Duchenne Muscular Dystrophy
    Heier, Christopher R.
    Tulley, Christopher B.
    Hamann, Karin S.
    Soslow, Jonathan H.
    Markham, Larry W.
    Olivieri, Laura J.
    Spurney, Christopher F.
    CIRCULATION, 2018, 138
  • [40] Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy A Randomized Clinical Trial
    Silva, Marly Conceicao
    Magalhaes, Tiago Augusto
    Alves Meira, Zilda Maria
    Reis Esselin Rassi, Carlos Henrique
    de Souza Andrade, Amanda Cristina
    Gutierrez, Paulo Sampaio
    Azevedo, Clerio Francisco
    Gurgel-Giannetti, Juliana
    Vainzof, Mariz
    Zatz, Mayana
    Kalil-Filho, Roberto
    Rochitte, Carlos Eduardo
    JAMA CARDIOLOGY, 2017, 2 (02) : 190 - 199